Priscila Carneiro Campos

This study shows SMURF2 inhibits autophagy against Mycobacterium tuberculosis in macrophages, suggesting it as a potential target for tuberculosis therapy.

This study identifies CMPK2 as a host factor that restricts Mycobacterium tuberculosis replication in human macrophages and alters gene expression related to innate immunity.

This study identifies SNX5 as a regulator of MHC-II antigen presentation during Mtb infection, linking endosomal sorting to immune responses against intracellular pathogens.

This study identifies USP15 as a negative regulator of autophagy and macrophage immunity to Mycobacterium tuberculosis, showing that its inhibition reduces bacterial burden.

This study develops a humanized lung-on-a-chip model to study early immune responses to Mycobacterium fortuitum infection, revealing cytokine and protease inhibitor upregulation.